- Home
- ACHC vs PLSE Comparison
ACHC vs PLSE Comparison
Compare ACHC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHC | PLSE |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.6B |
| IPO Year | 2011 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ACHC | PLSE |
|---|---|---|
| Price | $28.36 | $53.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 1 |
| Target Price | ★ $22.67 | $22.00 |
| AVG Volume (30 Days) | ★ 1.5M | 531.6K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $3,312,769,000.00 | N/A |
| Revenue This Year | $5.08 | $840.00 |
| Revenue Next Year | $5.98 | $287.54 |
| P/E Ratio | $563.80 | ★ N/A |
| Revenue Growth | ★ 5.04 | N/A |
| 52 Week Low | $11.43 | $12.56 |
| 52 Week High | $35.83 | $58.90 |
Technical Indicators
Market Signals| Indicator | ACHC | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 67.23 |
| Support Level | $26.62 | $24.27 |
| Resistance Level | $30.20 | N/A |
| Average True Range (ATR) | 1.41 | 3.85 |
| MACD | -0.01 | -0.21 |
| Stochastic Oscillator | 29.30 | 63.42 |
Price Performance
Historical ComparisonAbout ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.